US Stock MarketDetailed Quotes

VIRI Virios Therapeutics

Watchlist

0.215
+0.008+3.86%

Close May 31 16:00 ET

0.218
+0.003+1.44%

Post 18:29 ET

5.97MMarket Cap-797P/E (TTM)

Virios Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

44.81%-937.41K

57.53%-4.87M

45.00%-1.47M

61.32%-960.45K

79.70%-742.41K

36.05%-1.7M

26.91%-11.47M

48.41%-2.67M

6.25%-2.48M

-32.96%-3.66M

Net income from continuing operations

14.87%-1.29M

56.76%-5.3M

46.04%-1.1M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

23.26%-12.25M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

Change In working capital

162.62%214.95K

-198.51%-194.45K

33.76%-514.3K

275.94%126.32K

523.27%536.83K

-129.28%-343.28K

478.18%197.38K

2.80%-776.38K

-105.40%-71.79K

-108.47%-126.83K

-Change in prepaid assets

-97.73%3.42K

14.09%490.27K

-43.29%-385.71K

-42.21%159.2K

484.14%566.08K

-73.60%150.69K

571.53%429.74K

68.24%-269.18K

-72.69%275.48K

-108.38%-147.36K

-Change in payables and accrued expense

142.82%211.54K

-194.68%-684.71K

74.65%-128.6K

90.53%-32.89K

-242.48%-29.26K

-182.11%-493.97K

-696.61%-232.36K

-1,138.58%-507.2K

-208.34%-347.27K

107.87%20.54K

Cash from discontinued investing activities

Operating cash flow

44.81%-937.41K

57.53%-4.87M

45.00%-1.47M

61.32%-960.45K

79.70%-742.41K

36.05%-1.7M

26.91%-11.47M

48.41%-2.67M

6.25%-2.48M

-32.96%-3.66M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-74.25%1.16M

4,700.84%4.49M

-86K

Net common stock issuance

----

-74.25%1.16M

--0

----

1,621.38%4.49M

70.87%-86K

----

Cash from discontinued financing activities

Financing cash flow

----

-74.25%1.16M

--0

-74.73%1.16M

----

4,700.84%4.49M

---86K

--4.58M

--0

Net cash flow

Beginning cash position

-52.82%3.32M

-49.81%7.03M

-51.10%4.79M

-40.35%4.59M

-53.03%5.33M

-49.81%7.03M

-52.99%14.01M

-48.98%9.79M

-64.76%7.7M

-53.83%11.35M

Current changes in cash

44.81%-937.41K

46.77%-3.71M

46.72%-1.47M

-90.64%195.99K

79.70%-742.41K

36.05%-1.7M

55.80%-6.98M

46.75%-2.76M

179.03%2.09M

-32.96%-3.66M

End cash Position

-55.38%2.38M

-52.82%3.32M

-51.10%4.79M

-40.35%4.59M

-53.03%5.33M

-49.81%7.03M

-48.98%9.79M

-64.76%7.7M

Free cash flow

44.81%-937.41K

57.53%-4.87M

45.00%-1.47M

61.32%-960.45K

79.70%-742.41K

36.05%-1.7M

26.91%-11.47M

48.41%-2.67M

6.25%-2.48M

-32.96%-3.66M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	44.81%-937.41K	57.53%-4.87M	45.00%-1.47M	61.32%-960.45K	79.70%-742.41K	36.05%-1.7M	26.91%-11.47M	48.41%-2.67M	6.25%-2.48M	-32.96%-3.66M
Net income from continuing operations	14.87%-1.29M	56.76%-5.3M	46.04%-1.1M	52.05%-1.24M	60.71%-1.44M	61.70%-1.52M	23.26%-12.25M	54.68%-2.04M	37.33%-2.58M	14.38%-3.67M
Change In working capital	162.62%214.95K	-198.51%-194.45K	33.76%-514.3K	275.94%126.32K	523.27%536.83K	-129.28%-343.28K	478.18%197.38K	2.80%-776.38K	-105.40%-71.79K	-108.47%-126.83K
-Change in prepaid assets	-97.73%3.42K	14.09%490.27K	-43.29%-385.71K	-42.21%159.2K	484.14%566.08K	-73.60%150.69K	571.53%429.74K	68.24%-269.18K	-72.69%275.48K	-108.38%-147.36K
-Change in payables and accrued expense	142.82%211.54K	-194.68%-684.71K	74.65%-128.6K	90.53%-32.89K	-242.48%-29.26K	-182.11%-493.97K	-696.61%-232.36K	-1,138.58%-507.2K	-208.34%-347.27K	107.87%20.54K
Cash from discontinued investing activities
Operating cash flow	44.81%-937.41K	57.53%-4.87M	45.00%-1.47M	61.32%-960.45K	79.70%-742.41K	36.05%-1.7M	26.91%-11.47M	48.41%-2.67M	6.25%-2.48M	-32.96%-3.66M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities		-74.25%1.16M	0				4,700.84%4.49M	-86K
Net common stock issuance	----	-74.25%1.16M	--0	----	----	----	1,621.38%4.49M	70.87%-86K	----	----
Cash from discontinued financing activities
Financing cash flow	----	-74.25%1.16M	--0	-74.73%1.16M	----	----	4,700.84%4.49M	---86K	--4.58M	--0
Net cash flow
Beginning cash position	-52.82%3.32M	-49.81%7.03M	-51.10%4.79M	-40.35%4.59M	-53.03%5.33M	-49.81%7.03M	-52.99%14.01M	-48.98%9.79M	-64.76%7.7M	-53.83%11.35M
Current changes in cash	44.81%-937.41K	46.77%-3.71M	46.72%-1.47M	-90.64%195.99K	79.70%-742.41K	36.05%-1.7M	55.80%-6.98M	46.75%-2.76M	179.03%2.09M	-32.96%-3.66M
End cash Position	-55.38%2.38M	-52.82%3.32M	-52.82%3.32M	-51.10%4.79M	-40.35%4.59M	-53.03%5.33M	-49.81%7.03M	-49.81%7.03M	-48.98%9.79M	-64.76%7.7M
Free cash flow	44.81%-937.41K	57.53%-4.87M	45.00%-1.47M	61.32%-960.45K	79.70%-742.41K	36.05%-1.7M	26.91%-11.47M	48.41%-2.67M	6.25%-2.48M	-32.96%-3.66M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall